Bioavailability/Bioequivalence on Biopharmaceutical Products
The Bioavailability Bioequivalence Research Center aims to become a regional center of excellence for assuring the safety and efficacy of generic pharmaceutical products for human use. It plays a key role in the drug development period for both new drug products and their generic equivalents. These studies are also important in the post approval period in the presence of certain manufacturing changes. Information in the overall set of data that ensure the availability of safe and effective medicines to patients and practitioners can be discussed
- Factors affecting bae
- BABE studies
- Assesssment of bioeqivalence
- In vivo/In vitro studies
- Latest Updates In BA/BE
Related Conference of Bioavailability/Bioequivalence on Biopharmaceutical Products
February 28-March 01, 2019 ANA Crowne Plaza |
Global Pharmaceutical and Pharma Industry Conference
Osaka, Japan
March 18-20, 2019
20th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
Edinburgh, Scotland
March 18-19, 2019
13th International Conference on Biosimilars and Biologics
Amsterdam | Netherlands
July 26-27, 2019
13th Asian Biologics and Biosimilars Congress
Mercure Albert Park | Melbourne, Australia
Bioavailability/Bioequivalence on Biopharmaceutical Products Conference Speakers
Recommended Sessions
- Bioavailability/Bioequivalence on Biopharmaceutical Products
- Biologics and Biosimilars
- Biopharmaceutical Companies & Market Analysis
- Biopharmaceutical Pharmacovigilance
- Biopharmaceuticals
- Biopharmaceutics: Drug Discovery and Development
- Biotechnological Products
- Cellular and Gene Therapy
- clinical Trials on Biopharmaceutical Products
- Drug Delivery from Plant Extracts
- Drug Delivery System of Biopharmaceutical Products
- Drug Disposition & Pharmacokinetics
- Drug Dissolution of Biopharmaceutical Products
- Entrepreneurs Investment Meet
- Pharmaceutical Regulatory Affairs And IPR
- Pharmacovigilance
- Therapeutic Biological Products
Related Journals
Are you interested in
- BCS & IVIVC Based Biowaivers - Biosimilars Congress 2019 (Netherlands)
- Bio-Pharmaceutics - Pharma Congress 2018 (Poland)
- Bio-Pharmaceutics - Global Pharmaceutica 2019 (Japan)
- Bioequivalence Assessment - Biosimilars Congress 2019 (Netherlands)
- Bioequivalence Assessment - Asian Biosimilars 2019 (Australia)
- Biological Medicines - Biosimilars Congress 2019 (Netherlands)
- Biologics & Biosimilars - Global Pharmaceutica 2019 (Japan)
- Biologics & Biosimilars - Pharma Congress 2018 (Poland)
- Biologics and Biosimilars - Asian Biosimilars 2019 (Australia)
- Biomaterials in Drug Delivery - Global Pharmaceutica 2019 (Japan)
- Biopharmaceutical - Biosimilars Congress 2019 (Netherlands)
- Biopharmaceuticals - Asian Biosimilars 2019 (Australia)
- Biosimilars & Biologics: Clinical Studies & Trials - Asian Biosimilars 2019 (Australia)
- Biosimilars & Biologics: Current Challenges - Asian Biosimilars 2019 (Australia)
- Biosimilars Analytical Strategies - Asian Biosimilars 2019 (Australia)
- Biosimilars Approval to Biogenerics in Clinical Practice - Biosimilars Congress 2019 (Netherlands)
- Biosimilars Market Strategy - Biosimilars Congress 2019 (Netherlands)
- Biosimilars: Pharmacovigilance and Safety - Asian Biosimilars 2019 (Australia)
- Challenges in Biosimilars - Biosimilars Congress 2019 (Netherlands)
- Challenges in Biosimilars Pharmacovigilance - Asian Biosimilars 2019 (Australia)
- Clinical and Hospital Pharmacy - Pharma Congress 2018 (Poland)
- Clinical and Hospital Pharmacy - Global Pharmaceutica 2019 (Japan)
- Clinical Development Of Biosimilars - Asian Biosimilars 2019 (Australia)
- Clinical Trials and Clinical Research - Global Pharmaceutica 2019 (Japan)
- Clinical Trials and Clinical Research - Pharma Congress 2018 (Poland)
- Consequences of Brexit on Biosimilars - Biosimilars Congress 2019 (Netherlands)
- Current Agency Expectations for Approval for Biosimilars - Biosimilars Congress 2019 (Netherlands)
- Developing Biosimilars & Biobetters - Biosimilars Congress 2019 (Netherlands)
- Drug Targeting and Design - Global Pharmaceutica 2019 (Japan)
- Drug Targeting and Design - Pharma Congress 2018 (Poland)
- Emerging Biosimilars in Therapeutics - Biosimilars Congress 2019 (Netherlands)
- Formulation Strategies for Follow-on Biologics - Biosimilars Congress 2019 (Netherlands)
- Generic Biosimilars: Industrial Strategy - Biosimilars Congress 2019 (Netherlands)
- Globalization of Biosimilars - Asian Biosimilars 2019 (Australia)
- Globalization of Biosimilars - Biosimilars Congress 2019 (Netherlands)
- Industrial and Physical Pharmacy - Pharma Congress 2018 (Poland)
- Industrial and Physical Pharmacy - Global Pharmaceutica 2019 (Japan)
- Innovation and Technology for Biosimilar Development - Asian Biosimilars 2019 (Australia)
- Innovative Approaches for Biosimilars - Biosimilars Congress 2019 (Netherlands)
- Intellectual Property Rights - Biosimilars Congress 2019 (Netherlands)
- Legal Issues and BPCI Act - Biosimilars Congress 2019 (Netherlands)
- Medical Devices for Drug Delivery - Global Pharmaceutica 2019 (Japan)
- Nanomedicine and Biomedical Applications - Pharma Congress 2018 (Poland)
- Nanomedicine and Biomedical Applications - Global Pharmaceutica 2019 (Japan)
- Novel Drug Delivery Systems - Pharma Congress 2018 (Poland)
- Novel Drug Delivery Systems - Global Pharmaceutica 2019 (Japan)
- Novel Drug Delivery Technologies - Biosimilars Congress 2019 (Netherlands)
- Pharmaceutical Analysis - Global Pharmaceutica 2019 (Japan)
- Pharmaceutical Analysis - Pharma Congress 2018 (Poland)
- Pharmaceutical Biotechnology - Pharma Congress 2018 (Poland)
- Pharmaceutical Chemistry - Global Pharmaceutica 2019 (Japan)
- Pharmaceutical Chemistry - Pharma Congress 2018 (Poland)
- Pharmaceutical Formulation - Pharma Congress 2018 (Poland)
- Pharmaceutical Formulation - Global Pharmaceutica 2019 (Japan)
- Pharmaceutical Manufacturing - Global Pharmaceutica 2019 (Japan)
- Pharmaceutical Manufacturing - Pharma Congress 2018 (Poland)
- Pharmaceutical Microbiology - Pharma Congress 2018 (Poland)
- Pharmaceutical Nanotechnology - Pharma Congress 2018 (Poland)
- Pharmaceutical Nanotechnology - Global Pharmaceutica 2019 (Japan)
- Pharmaceutical Packaging - Global Pharmaceutica 2019 (Japan)
- Pharmaceutical Packaging - Pharma Congress 2018 (Poland)
- Pharmaceutical Process Validation - Global Pharmaceutica 2019 (Japan)
- Pharmaceutical Process Validation - Pharma Congress 2018 (Poland)
- Pharmaceutical Regulatory Affairs And IPR - Asian Biosimilars 2019 (Australia)
- Pharmacogenetics and Genomics - Global Pharmaceutica 2019 (Japan)
- Pharmacogenetics and Genomics - Pharma Congress 2018 (Poland)
- Pharmacognosy and Phytochemistry - Pharma Congress 2018 (Poland)
- Pharmacokinetics and Pharmacodynamics in Drugs - Global Pharmaceutica 2019 (Japan)
- Pharmacological Sciences - Pharma Congress 2018 (Poland)
- Pharmacology and Drug Development - Biosimilars Congress 2019 (Netherlands)
- Pharmacovigilance and Drug Safety - Pharma Congress 2018 (Poland)
- Pharmacovigilance and Drug Safety - Global Pharmaceutica 2019 (Japan)
- Pharmacovigilance Challenges and Safety - Biosimilars Congress 2019 (Netherlands)
- Pharmacy Education and Practice - Pharma Congress 2018 (Poland)
- Pharmacy Education and Practice - Global Pharmaceutica 2019 (Japan)
- Plant Produced Biosimilars - Biosimilars Congress 2019 (Netherlands)
- Protein Biotherapeutics and Biosimilars - Biosimilars Congress 2019 (Netherlands)
- Regulatory Advances in Biosimilars - Biosimilars Congress 2019 (Netherlands)
- Regulatory Affairs and Intellectual Property Rights - Global Pharmaceutica 2019 (Japan)
- Regulatory Affairs and Intellectual Property Rights - Pharma Congress 2018 (Poland)
- Regulatory Approach for Biosimilars - Asian Biosimilars 2019 (Australia)
- Smart Drug Delivery Systems - Global Pharmaceutica 2019 (Japan)
- Therapeutic Biological Products - Asian Biosimilars 2019 (Australia)
- USFDA Approved Biosimilars - Biosimilars Congress 2019 (Netherlands)
- Vaccine Drug Delivery Systems - Global Pharmaceutica 2019 (Japan)
